FDA agrees to meeting with Enochian over HIV therapy
The US authority has said yes to a meeting with Enochian Biosciences to discuss a potential start to clinical trials of the company's HIV treatment. The biotech company is also looking to raise funds.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
Enochian Biosciences has secured a meeting with the US Food and Drug Administration (FDA). This means the company is sticking to its previously announced schedule, which predicted discussions with the authority would start in 2021.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
